for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Agenus Receives Fast Track Designation For Balstilimab & Zalifrelimab In Advanced Cervical Cancer

March 12 (Reuters) - Agenus Inc:

* AGENUS RECEIVES FAST TRACK DESIGNATION FOR BALSTILIMAB & ZALIFRELIMAB IN ADVANCED CERVICAL CANCER

* AGENUS INC - EXPECTS TO FILE 2 BLAS THIS YEAR FOR ACCELERATED APPROVAL OF COMBINATION OF BALSTILIMAB AND ZALIFRELIMAB AND BALSTILIMAB MONOTHERAPY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up